Trial · NCT01952418
Effect of Video Monitor Size on Adenoma Detection Rate
NCT01952418, Not applicable, Completed, Massachusetts General Hospital; results first posted 2017-04-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Video Monitor Size on Adenoma Detection Rate. Trials, record NCT01952418. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01952418
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Video Monitor Size on Adenoma Detection Rate
- NCT number
- NCT01952418
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,805 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- Colon Adenoma
- Interventions
- Monitor size
- First posted
- 2013-09-30
- Last updated
- 2017-05-30
- Results first posted
- 2017-04-14
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adenoma Detection Rate (All Indications) | within 2 weeks (range of 1 day-14 days) of the endoscopy | Number of patients with adenoma detected |
| Primary | Adenoma Detection Rate (Screening Exams Only) | within 2 weeks (range of 1 day-14 days) of the endoscopy | Number of patients with adenoma detected |
| Secondary | Polyp Detection Rate (All Indications) | recorded during endoscopy (immediate) | Number of patients with polyps detected |
| Secondary | Polyp Detection Rate (Screening Exams Only) | recorded during endoscopy (immediate) | Number of patients with polyps detected |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Adenoma Detection Rate (All Indications) | within 2 weeks (range of 1 day-14 days) of the endoscopy | all indications | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Adenoma Detection Rate (Screening Exams Only) | within 2 weeks (range of 1 day-14 days) of the endoscopy | screening exams only | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Polyp Detection Rate (All Indications) | recorded during endoscopy (immediate) | all indications | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Polyp Detection Rate (Screening Exams Only) | recorded during endoscopy (immediate) | screening exams only | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Adenoma Detection Rate (All Indications) | Standard Monitor (24) | 264 | Participants | ||
| Adenoma Detection Rate (All Indications) | Large Monitor (32) | 271 | Participants | ||
| Adenoma Detection Rate (Screening Exams Only) | Standard Monitor (24) | 137 | Participants | ||
| Adenoma Detection Rate (Screening Exams Only) | Large Monitor (32) | 157 | Participants | ||
| Polyp Detection Rate (All Indications) | Standard Monitor (24) | 367 | Participants | ||
| Polyp Detection Rate (All Indications) | Large Monitor (32) | 424 | Participants | ||
| Polyp Detection Rate (Screening Exams Only) | Standard Monitor (24) | 137 | Participants | ||
| Polyp Detection Rate (Screening Exams Only) | Large Monitor (32) | 157 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard Monitor (24) | 910 | |
| Overall Study | STARTED | Large Monitor (32) | 895 | |
| Overall Study | COMPLETED | Standard Monitor (24) | 910 | |
| Overall Study | COMPLETED | Large Monitor (32) | 895 | |
| Overall Study | NOT COMPLETED | Standard Monitor (24) | 0 | |
| Overall Study | NOT COMPLETED | Large Monitor (32) | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard Monitor (24) | ||
| Total, all-cause mortality | Large Monitor (32) | ||
| Total, other adverse events | Standard Monitor (24) | 0 | 910 |
| Total, other adverse events | Large Monitor (32) | 0 | 895 |
| Total, serious adverse events | Standard Monitor (24) | 0 | 910 |
| Total, serious adverse events | Large Monitor (32) | 0 | 895 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 30986402 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons5
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Standard Monitor (24) vs Large Monitor (32): Polyp Detection Rate (All Indications) | Trial comparisons |
| Standard Monitor (24) vs Large Monitor (32): Polyp Detection Rate (Screening Exams Only) | Trial comparisons |
| Standard Monitor (24) vs Large Monitor (32): Adenoma Detection Rate (Screening Exams Only) | Trial comparisons |
| Standard Monitor (24) vs Large Monitor (32): Adenoma Detection Rate (All Indications) | Trial comparisons |
| Standard Monitor (24) vs Large Monitor (32): serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01952418
GET https://conductscience.org/api/trials/v1/NCT01952418/registered